Structures by: Du S. Z.
Total: 7
C33H40O4
C33H40O4
Journal of medicinal chemistry (2020)
a=9.4737(2)Å b=15.6173(3)Å c=18.4421(4)Å
α=90° β=90° γ=90°
C30H44O5
C30H44O5
Journal of medicinal chemistry (2020)
a=10.5518(3)Å b=16.1297(5)Å c=17.0893(5)Å
α=90° β=90° γ=90°
C8H13MoN2O5,0.5(C2H10N2)
C8H13MoN2O5,0.5(C2H10N2)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8697-8702
a=17.2729(12)Å b=6.4159(5)Å c=11.6210(9)Å
α=90.00° β=96.4500(10)° γ=90.00°
4(C9H14MoN2O5),4(C3H12N2),2(C0.8H2O0.2)
4(C9H14MoN2O5),4(C3H12N2),2(C0.8H2O0.2)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8697-8702
a=11.3739(10)Å b=12.4797(11)Å c=13.2237(15)Å
α=100.168(2)° β=91.3540(10)° γ=90.0950(10)°
C40H44Mo0.75N2O10W0.25
C40H44Mo0.75N2O10W0.25
Crystal Growth & Design (2014) 14, 7 3249
a=26.998(2)Å b=10.2720(10)Å c=13.3181(12)Å
α=90.00° β=92.4600(10)° γ=90.00°
C40H44N2O10W
C40H44N2O10W
Inorganic Chemistry (2013) 52, 9470-9478
a=27.215(3)Å b=10.2110(10)Å c=13.5221(12)Å
α=90.00° β=93.2330(10)° γ=90.00°
C40H44MoN2O10
C40H44MoN2O10
Inorganic Chemistry (2013) 52, 9470-9478
a=26.990(3)Å b=10.367(1)Å c=13.2831(13)Å
α=90.000° β=92.028(1)° γ=90.000°